RDD Asia 2014 co-sponsor Aptar Pharma has announced that registration for the meeting is now open. According to the announcement, the organizers expect more than 200 OINDP specialists to attend the first Asian RDD meeting, which will take place November 12-14 at the Goa Marriott Resort & Spa in Goa, India. Early registration discounts are available through July 31.
According to Aptar and RDD Online, “RDD Asia 2014 seeks to link Asian regulators, industrial and academic scientists, clinicians and business professionals with their international counterparts, together working toward the goal of advancing inhaled and nasal drug therapy worldwide. RDD Asia, like its predecessors in the US and Europe, will feature lively, fresh and focused updates on respiratory drug delivery in Asia and the rest of the world.”
Meeting topics include:
• Global Regulation of Inhaled and Nasal Drug Products
• New Therapeutic Opportunities
• Generic Product Development
• Advanced Drug Delivery Technologies
• Current Issues in Inhaled and Nasal Drug Product Testing
Aptar Pharma India’s VP India and Southeast Asia Kanwal Tikoo commented, “With Aptar Pharma’s strong presence in India and RDD Online’s extensive experience in organizing high quality scientific conferences, there is so much to gain from the workshops, exhibitions and networking opportunities. We are proud to contribute to the advance of inhaled drug therapy in Asia and worldwide.”
View RDD Asia 2014 registration information.
